Dan Doyle

The discovery and study of human cells began in the 19th century, but it wasn’t until the latter part of 20th century that cells were understood in enough detail to begin observing and theorizing the forms of signaling behind cell activity. By 1999, the role of redox within cell signaling was understood and formalized enough to prompt the creation of a peer-reviewed scientific journal on the topic.

The processes of metabolism and cellular respiration saw discoveries in the 1930s and ’40s that illuminated the methods by which the human body uses oxygen and redox processes to fuel vital functions. Research in the 1950s and ’60s provided early clues into the molecular basis of cell signaling, though scientific papers didn’t begin talking about cell signaling as a distinct discipline consistently until the ’80s and ’90s.

ASEA Founder Verdis Norton was first introduced to redox signaling biochemistry while serving on the board of a Utah biotech company. The company’s preliminary work in redox molecule synthesis had produced promising results, but a lack of funds forced them to shelf the project early. Convinced of its breakthrough potential, Verdis and a few close partners pooled resources to acquire the discontinued tech and revive the research. ASEA commissioned its own team of medical professionals, scientists, and engineers to advance the technology, conducting a comprehensive safety analysis and producing a scalable method of production for ASEA REDOX Cell Signaling Supplement and future redox signaling products.